KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 71 filers reported holding KRONOS BIO INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $3,456,643 | -3.8% | 2,765,314 | 0.0% | 4.12% | -26.0% |
| Q3 2023 | $3,594,908 | -24.4% | 2,765,314 | 0.0% | 5.56% | -10.4% |
| Q2 2023 | $4,756,340 | +17.8% | 2,765,314 | 0.0% | 6.21% | +12.4% |
| Q1 2023 | $4,037,358 | -9.9% | 2,765,314 | 0.0% | 5.52% | -8.2% |
| Q4 2022 | $4,479,809 | -51.6% | 2,765,314 | 0.0% | 6.02% | -27.6% |
| Q3 2022 | $9,264,000 | -8.0% | 2,765,314 | 0.0% | 8.31% | -2.3% |
| Q2 2022 | $10,066,000 | -49.7% | 2,765,314 | 0.0% | 8.51% | -26.8% |
| Q1 2022 | $19,993,000 | -46.8% | 2,765,314 | 0.0% | 11.63% | -17.3% |
| Q4 2021 | $37,581,000 | -35.2% | 2,765,314 | 0.0% | 14.06% | -15.3% |
| Q3 2021 | $57,961,000 | -12.5% | 2,765,314 | 0.0% | 16.60% | -0.0% |
| Q2 2021 | $66,229,000 | -18.2% | 2,765,314 | 0.0% | 16.61% | -18.8% |
| Q1 2021 | $80,941,000 | -2.0% | 2,765,314 | 0.0% | 20.45% | +20.6% |
| Q4 2020 | $82,600,000 | – | 2,765,314 | – | 16.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $4,037,358 | 5.52% |
| Omega Fund Management, LLC | 3,818,283 | $5,574,693 | 3.64% |
| Nextech Invest Ltd. | 1,451,537 | $2,119,244 | 0.88% |
| Wildcat Capital Management, LLC | 1,297,959 | $1,895,020 | 0.70% |
| Privium Fund Management (UK) Ltd | 292,182 | $455,804 | 0.36% |
| CM Management, LLC | 180,000 | $263 | 0.31% |
| Artal Group S.A. | 1,542,954 | $2,253 | 0.13% |
| Alphabet Inc. | 1,438,232 | $2,099,819 | 0.12% |
| Perceptive Advisors | 1,752,745 | $2,558,131 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 406,362 | $593 | 0.06% |